Pt Hetzer Medical Stock Net Income
| MEDS Stock | 50.00 0.00 0.00% |
PT Hetzer Medical fundamentals help investors to digest information that contributes to PT Hetzer's financial success or failures. It also enables traders to predict the movement of MEDS Stock. The fundamental analysis module provides a way to measure PT Hetzer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Hetzer stock.
MEDS |
PT Hetzer Medical Company Net Income Analysis
PT Hetzer's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, PT Hetzer Medical reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The net income for all Indonesia stocks is 100.0% higher than that of the company.
MEDS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PT Hetzer's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PT Hetzer could also be used in its relative valuation, which is a method of valuing PT Hetzer by comparing valuation metrics of similar companies.PT Hetzer is currently under evaluation in net income category among its peers.
MEDS Fundamentals
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.12 % | |||
| Shares Outstanding | 1.56 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Price To Sales | 5.97 X | |||
| Revenue | 43.99 B | |||
| Gross Profit | 53.98 B | |||
| EBITDA | 7.68 B | |||
| Book Value Per Share | 45.78 X | |||
| Number Of Employees | 25 | |||
| Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.